The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Computer-assisted Curie scoring for metaiodobenzylguanidine (mIBG) scans in patients with neuroblastoma.
 
Elizabeth Sokol
No Relationships to Disclose
 
Roger Engelmann
Research Funding - Biomet (Inst); Philips Healthcare (Inst); Riverain Technologies (Inst)
Patents, Royalties, Other Intellectual Property - Receives royalties and licensing fees for CAD technologies through the University of Chicago
 
Navin R. Pinto
No Relationships to Disclose
 
Adam Starkey
Leadership - YellowDot Innovations
 
Melanie Nall
No Relationships to Disclose
 
Hollie Lai
Research Funding - Siemens
 
Helen R Nadel
No Relationships to Disclose
 
Barry L. Shulkin
Consulting or Advisory Role - Navidea
 
Yonglin Pu
No Relationships to Disclose
 
Daniel Applebaum
No Relationships to Disclose
 
Gregory A. Yanik
No Relationships to Disclose
 
Susan Lerner Cohn
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I); Celgene; Dr. Reddy's Laboratories; Edwards Lifesciences; Edwards Lifesciences (I); Endo Health Solutions (I); Fresenius (I); Hansen Medical; Henry Schein; Mednax; Merck; Merck (I); Novartis; Pfizer; Pfizer (I); Resmed (I); Teva; United Health Group; United Therapeutics; United Therapeutics (I); Universal Health Services; Universal Health Services (I); Varian Medical Systems; Varian Medical Systems (I); Vermillion
Research Funding - United Therapeutics (Inst)
Travel, Accommodations, Expenses - Novartis; United Therapeutics
 
Samuel Armato, III
Consulting or Advisory Role - Aduro Biotech
Patents, Royalties, Other Intellectual Property - I receive royalties and licensing fees related to computer-aided diagnosis technology through my institution.
Travel, Accommodations, Expenses - Aduro Biotech
 
Samuel Louis Volchenboum
No Relationships to Disclose